Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from panax or acanthopanax
Reexamination Certificate
2007-10-30
2007-10-30
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from panax or acanthopanax
C424S725000, C424S729000, C424S737000, C424S641000, C424S702000, C424S630000, C424S769000, C514S532000, C514S533000, C514S458000, C514S706000, C514S885000
Reexamination Certificate
active
10612242
ABSTRACT:
The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.
REFERENCES:
patent: 2073616 (1937-03-01), Acree
patent: 4454286 (1984-06-01), Daniels et al.
patent: 4950751 (1990-08-01), DeWitt
patent: 5080906 (1992-01-01), Carenzi et al.
patent: 5096708 (1992-03-01), Gohla et al.
patent: 5545673 (1996-08-01), Kelly
patent: 5780060 (1998-07-01), Levy et al.
patent: 5788971 (1998-08-01), Togasaki
patent: 5906852 (1999-05-01), Klemann et al.
patent: 5972993 (1999-10-01), Ptchelintsev
patent: 5998330 (1999-12-01), Felton
patent: 6083921 (2000-07-01), Xu
patent: 6331565 (2001-12-01), Dong et al.
patent: 6632459 (2003-10-01), Graus et al.
patent: 1179948 (1998-04-01), None
patent: 0 317 453 (1989-05-01), None
patent: 0 606 080 (1994-07-01), None
patent: 0 906 761 (1999-04-01), None
patent: 1 008 344 (2000-06-01), None
patent: 2715301 (1995-07-01), None
patent: 60-243016 (1985-03-01), None
patent: WO 92/13896 (1992-08-01), None
patent: WO 98/11778 (1998-03-01), None
patent: WO 99/34812 (1999-07-01), None
Coudray et al. Br. J. Nutrition. 1998. vol. 80, No. 6, pp. 575-584.
Chekalinskaya et al. Rastitel'nye Resursy. 1983. vol. 19, No. 1, p. 80-84, CAPLUS Abstract enclosed.
Ameziane et al. Bulletin de la Societe Chimique de France. vol. 133, No. 3, pp. 243-249.
Robinson et al. Molecular Pharmacology. 1996. vol. 50, pp. 846-855.In re Sussman, 1943 C.D. 518.
Exon et al., “Effect of Dietary Chlorogenic Acid on Multiple Immune Functions and Formation of Aberrant Crypt Foci in Rats,”J. Toxicology and Environmental Health, Part A, 53:375-384 (1998).
King et al., “Structure-Activity Relationships: Analogues of the Dicaffeoylquinic and Dicaffeoltartaric Acids as Potent Inhibitors of Human Immunodeficiency Virus Type I Integrase and Replication,”J. Med. Chem., 42:497-509 (1999).
Panizzi et al.,Gazz. Chim. Ital., 86:913 (1956).
Zhu et al., “Irreversible Inhibition of Human Immunodeficiency Virus Type 1 Integrase by Dicaffeoylquinic Acids,”J. Virology, 73(4):3309-3316 (1999).
Dorland's Medical Dictionary, 27thed. pp. 369 and 1043 (1988).
English abstract of EP 0 317 453.
Graus Yvo Maria Franciscus
Hageman Robert Johan Joseph
Osterhaus Albertus Dominicus Marcellinus Erasmus
Smit Hobbe Friso
Banner & Witcoff , Ltd.
Nutricia N.V.
Tate Christopher R.
LandOfFree
Chlorogenic acid and an analog thereof for immune system... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlorogenic acid and an analog thereof for immune system..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlorogenic acid and an analog thereof for immune system... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898197